Company Overview
Founded2023
Company Size1-50 employees
IndustryBiotechnology
Last Funding$180M post_ipo_equity

Spyre Therapeutics

👥 1-50💰 $180,000,000 Post-IPO Equity about 2 years agoBiotechnologyTherapeutics📈 Public Company
Website LinkedIn Twitter

Spyre Therapeutics is a biotechnology company focused on developing innovative antibody therapies aimed at transforming the treatment landscape for inflammatory bowel disease (IBD).

Spyre Therapeutics is a biotechnology company focused on developing innovative antibody therapies aimed at transforming the treatment landscape for inflammatory bowel disease (IBD).

Tech Stack
hosting

Related companies:

Jobs at this company:

USFull-TimeBiotechnologyPosted 2 months ago
LeadershipProject ManagementCross-functional Team Leadership+2 more